Osteotech gets US nod for spinal GraftCage interbody devices:
This article was originally published in Clinica
The US FDA has given Osteotech the all-clear to sell its GraftCage ACX product for replacing a collapsed, damaged, or unstable vertebral body in the thoracic or lumbar spine. The device, which restores the height of a collapsed vertebral body, features titanium markers to facilitate intra-operative and post-operative radiographic assessments. It also has an opening for the insertion of bone grafting materials, including a new form of the firm's recently introduced Xpanse bone insert, to allow for maximum graft exposure. GraftCage is scheduled for launch in the first quarter of 2006.